In CD82-upregulated mouse HCC Hepa1-6 cells, GM3 alone or GM2/GM3 co-expression enhanced the CD82-mediated inhibition of HGF-induced tyrosine phosphorylation of c-Met at Tyr1313 and Tyr1365 [15]. The gene discussed is MET; the disease is hepatocellular carcinoma.